Join us for an insightful webinar focused on the latest advancements in the treatment of type 2 diabetes with SGLT2 inhibitors and GLP-1 receptor agonists.. Recent studies continue to highlight the benefits of SGLT2 inhibitors in not only controlling blood sugar levels but also in reducing the risk of heart failure and kidney disease complications among diabetes patients. Similarly, GLP-1 receptor agonists have shown remarkable efficacy in managing blood sugar levels and promoting weight loss.
Dr. Abhyudaya Verma
Assoc Professor Department of Endocrinology Index Medical College and Research Institute Indore MP
